American Academy of Child and Adolescent Psychiatry 71st Annual Meeting 2024

American Academy of Child and Adolescent Psychiatry 71st Annual Meeting 2024

+ Include: 191 videos + 191 audios, size: 289 GB

+ Target Audience: child and adolescent psychiatrists, general psychiatrists, psychologists, psychiatric nurses, social workers, pediatricians

+ Information:

The American Academy of Child and Adolescent Psychiatry (AACAP) 71st Annual Meeting 2024 is the premier event for professionals dedicated to improving the mental health of children and adolescents. This comprehensive conference brings together leading clinicians, researchers, and educators to share the latest advancements in diagnosis, treatment, and prevention of psychiatric disorders in young people. Through keynote lectures, symposia, workshops, and networking events, participants will gain evidence-based insights and practical skills to enhance clinical practice and advance the field.

What You Will Learn

• Current research and innovations in child and adolescent psychiatry

• Best practices in the diagnosis and management of psychiatric disorders in youth

• Advances in psychopharmacology, psychotherapy, and integrated care

• Strategies for addressing mental health disparities and promoting equity

• Approaches for collaborating across disciplines and systems of care

Event Details

• Event: American Academy of Child and Adolescent Psychiatry 71st Annual Meeting 2024

• Format: In-person conference with select virtual participation options

• Program Highlights: Plenary sessions, symposia, clinical workshops, poster presentations, and networking opportunities

• Topics Covered: ADHD, mood disorders, anxiety, autism spectrum disorders, trauma, psychopharmacology, public policy, and emerging treatments

Who Should Attend
Child and adolescent psychiatrists, general psychiatrists, psychologists, psychiatric nurses, social workers, pediatricians, mental health counselors, researchers, and trainees in the field of child and adolescent mental health.

Why Attend
This meeting offers a unique opportunity to learn from top experts, engage in high-quality educational sessions, and connect with peers committed to advancing mental health care for children and adolescents. Attendees will leave with actionable strategies, updated clinical knowledge, and expanded professional networks.

 

+ Topics:

1. Suicide Prevention & Self-Harm

• Beyond deaths of despair in rural youth (Clinical Perspectives 01)

• Suicide prevention champions & leadership (Institute 2.1)

• Training & program implementation (Institute 2.2–2.4)

• Treatment interventions for suicidal youth (Institute 2.5)

• Zero Suicide & caring contacts (Institute 2.6)

• Quality improvement to reduce suicide rates (Institute 2.7)

• Suicide in ASD (Institute 4.3)

• Suicide prevention research (Symposium 04, 08, 11)

---

2. Autism Spectrum Disorder (ASD) & Intellectual Developmental Disorder (IDD)

• Empowering families of children with ASD (Clinical Perspectives 03)

• Ethical dilemmas in ASD/IDD (Clinical Perspectives 25)

• Incarceration prevention & reintegration (Clinical Perspectives 17)

• ASD & anxiety (Clinical Perspectives 15, Institute 4.1)

• Catatonia in ASD (Institute 4.2)

• Depression in ASD, esp. females (Institute 4.3)

• ADHD in ASD (Institute 4.4)

• Irritability & bipolar in ASD (Institute 4.5)

• Rethinking social competence (Institute 4.6)

• Transition & neurodivergence (Institute 4.7)

• Neurogenetic syndromes vs idiopathic ASD (Clinical Perspectives 56)

• Pharmacological management of maladaptive behaviors (Clinical Perspectives 68)

• New perspectives on ASD (Clinical Perspectives 90)

• Emerging mechanisms in ASD (Symposium 15)

• Spectrum of rigidity & compulsivity (Symposium 28)

• Big data in neurodevelopmental conditions (Symposium 29)

---

3. ADHD & Disruptive Behavior Disorders

• Internet addiction & ADHD (Clinical Perspectives 09)

• Comorbid ADHD therapeutics (Clinical Perspectives 20)

• ADHD in college students (Clinical Perspectives 44)

• Pharmacological strategies in ADHD (Institute 3.1)

• What’s new in ADHD (Institute 5.2)

• Irritability & aggression in ADHD (Institute 7.1)

• Mood disorders in ADHD (Institute 7.2)

• ASD & ADHD (Institute 7.3)

• ADHD & tics (Institute 7.4)

• ADHD & substance use disorders (Institute 7.5)

• CNS stimulants & weight, growth, sleep, cardiovascular effects (Institute 7.6–7.8)

• Treatment of ADHD in young children (Institute 8.4)

• Early ADHD identification (Symposium 30)

• Sleep & neurofeedback in ADHD (Symposium 20)

---

4. Substance Use & Addiction

• Psychosis & substance use overlap (Clinical Perspectives 04)

• Social media & substance use (Clinical Perspectives 36)

• Youth opioid use disorder & MAT barriers (Clinical Perspectives 50)

• Addiction in transitional-age youth (Clinical Perspectives 58)

• ADHD & substance use disorders (Institute 7.5)

• Psychopharmacology of SUD in youth (Institute 3.6)

• New findings on youth substance use & co-occurring disorders (Institute 5.3)

• Alcohol initiation risk factors (Symposium 32)

---

5. Trauma, Violence & Adversity

• Trauma in IDD spectrum (Clinical Perspectives 08)

• Fetal alcohol spectrum disorder (Clinical Perspectives 27)

• Children & war (Clinical Perspectives 34)

• Trauma of pediatric illness (Clinical Perspectives 69)

• Addressing sexual trauma in girls (Institute 1.1)

• Trauma, resilience, prevention (Institute 5.1)

• Treating traumatized young children (Institute 8.2)

• New research on traumatized children (Symposium 38)

• Intergenerational trauma & parent–child relationship (Symposium 25)

---

6. School, Bullying & Education Systems

• Bullying & school mental health (Clinical Perspectives 12)

• School support & transition to college (Clinical Perspectives 32)

• School-based collaborative care (Clinical Perspectives 52)

• Preschool treatment planning & behavioral interventions (Institute 8.1, 8.7)

---

7. Climate Change & Environment

• Effects of climate change on families (Clinical Perspectives 14)

• Green space benefits (Clinical Perspectives 19)

• Psychological trauma of climate change (Clinical Perspectives 28)

• Cross-cultural climate change perspectives (Clinical Perspectives 31)

• Plenary research on climate change & youth (Plenary 2)

---

8. Eating Disorders

• Starvation effects in youth (Clinical Perspectives 07)

• Eating disorders in girls (Institute 1.2)

• Ethical/legal issues in eating disorders (Clinical Perspectives 38)

• Rise of eating disorders in Hispanic communities (Clinical Perspectives 63)

• Very young & severely underweight cases (Clinical Perspectives 78)

• Atypical anorexia nervosa challenges (Clinical Perspectives 80)

• Eating disorders screening & transitions (Symposium 37)

---

9. Gender Diversity & Sexuality

• Supporting transgender youth under care bans (Clinical Perspectives 22)

• Unseen identities: asexuality, nonmonogamy (Clinical Perspectives 70)

• Working with racially diverse transgender youth (Institute 5.6)

---

10. Psychopharmacology & Treatment

• Tourette’s disorder clinical dilemmas (Clinical Perspectives 41)

• DBT implementation challenges (Clinical Perspectives 37)

• Pediatric delirium innovations (Clinical Perspectives 33)

• Managing aggression (Clinical Perspectives 72)

• Prescribing in early psychosis (Clinical Perspectives 87)

• Psychopharmacology basics for complex youth (Clinical Perspectives 88)

• Ketamine in psychiatry (Clinical Perspectives 65)

• Pediatric mood disorders interventions (Symposium 16)

• Antipsychotic/antidepressant safety (Symposium 19)

---

11. Social Media & Technology

• Adolescent sexual development (Clinical Perspectives 13)

• Parasocial relationships (Clinical Perspectives 39)

• AI in child psychiatry (Clinical Perspectives 46, 74)

• Parent problematic media use (Clinical Perspectives 81)

• Social media psychoeducation & contagion (Clinical Perspectives 86)

• AI & social media impacts (Institute 5.4)

• Digital & AI in behavioral health (Symposium 18)

• Screen media behavior & psychiatric outcomes (Symposium 02)

---

12. Systems, Policy & Leadership

• Quality improvement in ED settings (Clinical Perspectives 05)

• Leadership strategies (Clinical Perspectives 24)

• Grassroots systems transformation (Clinical Perspectives 55)

• Rural access innovations (Clinical Perspectives 67)

• Landmark cases guiding psychiatry (Clinical Perspectives 49)

• Systemic change leadership (Clinical Perspectives 85)

• Justice-involved youth support (Clinical Perspectives 83)

• Pediatric mental health boarding crisis (Clinical Perspectives 93)

• Child psychiatry access programs (Clinical Perspectives 89)

• Plenary sessions on tribal communities, foster care, systems change (Plenary 1, 3, 6)